The Registry of Oncology Outcomes Associated With Testing and Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Principal Investigator - Raymond Bergan, MD
OHSU Knight Cancer Institute
Principal Investigator - Razelle Kurzrock, MD
Moores Cancer Center at University of California at San Diego
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Teton Cancer Institute
Idaho Falls, Idaho, United States
- Oncology and Hematology of South Texas
Laredo, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 May 2021
- Primary completion
- 31 Oct 2024
- Completion
- 31 Oct 2024
- Last update posted
- 18 Dec 2024
- Registered enrollment
- 167
- Registry id
- NCT04028479
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.